Emerging evidence and clinical reports suggest mold exposure may drive complex inflammatory syndromes, requiring sharper diagnostics and integrative treatment strategies.
Experts in functional medicine, including clinicians interviewed by The Independent and practitioners cited in Advanced Functional Medicine, point to Chronic Inflammatory Response Syndrome (CIRS) as a major consequence of prolonged mold exposure. CIRS is described as a multi-system inflammatory condition triggered by biotoxins in genetically susceptible individuals.
Discussion around public figure Jordan Peterson has amplified awareness of the diagnosis. Experts argue that mold toxins can disrupt immune signaling, impair detoxification pathways, and create persistent inflammatory cascades. Medical interest centers on diagnostic markers (HLA-DR genotyping, C4a, TGF-β1, MMP-9) and evidence-based treatment protocols.
Science and medical journals have been reporting on an increasing prevalence of mold-related health problems since 2007, at least. This article aims to provide updated information for primary care physicians and other experts.
Chronic Inflammatory Response Syndrome: A Biotoxin-Driven Condition
Chronic Inflammatory Response Syndrome (CIRS) has moved from the periphery of environmental medicine into broader clinical conversation. CIRS is described as a multi-system inflammatory illness triggered by biotoxins, including mold toxins, in genetically susceptible individuals.
Public awareness increased after Canadian psychologist Jordan Peterson discussed his struggle with symptoms allegedly linked to mold exposure, according to The Independent. While controversy remains, clinicians in functional medicine argue the pathophysiology warrants serious evaluation.
According to Advanced Functional Medicine, mold-derived biotoxins can dysregulate innate immune signaling, particularly in patients with specific HLA-DR genotypes. This leads to persistent elevation of inflammatory mediators such as C4a, TGF-β1, and MMP-9, alongside hormonal disruption and mitochondrial impairment.
“Mold toxicity can trigger widespread immune dysfunction,” notes the publication, emphasizing that patients often present with fatigue, cognitive impairment, neuropathy, and chronic sinus issues.
For medical professionals, the clinical question is less whether mold exists and more how to objectively identify susceptibility. Diagnostic approaches proposed in functional medicine include HLA typing, inflammatory markers, visual contrast sensitivity testing, and careful environmental history-taking.
Mycotoxins and Mold Colonization: Local Infection, Systemic Effects
Beyond environmental exposure, some practitioners argue that mold can colonize sinus cavities or lungs, particularly in immunocompromised individuals.
Dr. Will Cole states on his clinical platform that mold colonization may persist in the sinuses and contribute to chronic inflammation
“Mold infection (colonization in sinus cavities, lungs, aspergillosis) can drive systemic symptoms,” he explains.
Aspergillus species, commonly implicated in indoor mold exposure, can produce mycotoxins capable of affecting neurological and gastrointestinal systems. In susceptible individuals, mycotoxins may impair detoxification pathways, disrupt the gut microbiome, and alter cytokine signaling.
Similarly, Dr. Peter Osborne notes in a public lecture that “once you’re in mold consistently, it can cause anything that Lyme can cause or heavy metals or gluten.” While this comparison is debated, the underlying premise is that chronic toxin exposure may lead to overlapping inflammatory and autoimmune-like symptom profiles.
Clinicians must differentiate:
- Allergic fungal sinusitis
- Invasive fungal infections (e.g., aspergillosis)
- Non-invasive colonization
- Systemic inflammatory response to environmental mycotoxins
Imaging, fungal cultures, serum IgE/IgG panels, galactomannan testing (for invasive aspergillosis), and urinary mycotoxin assays are among the tools used in specialized practices.
Diagnostics and Treatment: Moving Toward Structured Protocols
One of the most contentious aspects of mold toxicity is clinical validation. Critics cite inconsistent laboratory standards, while proponents argue under-recognition is the greater risk.
Functional medicine sources recommend a multi-pronged evaluation:
- Inflammatory markers (C4a, TGF-β1, MMP-9)
- Hormonal panels (ADH/osmolality)
- Nutrient testing (zinc, magnesium, glutathione status)
- Gut permeability and microbiome assessment
- Environmental mold inspection
Treatment strategies focus on three pillars: removal from exposure, toxin binding, and immune modulation.
Cholestyramine and natural elements like black charcoal are cited as a binder for biotoxins, while glutathione and NAC are used to support detoxification pathways. In cases of confirmed colonization, antifungal therapy may be appropriate. Dietary interventions—often anti-inflammatory and gluten-free—are recommended when systemic inflammation or nutrient malabsorption is present.
As noted by clinicians interviewed on integrative health platforms, failure to address environmental remediation can render treatment ineffective.
The debate continues regarding the standardization of testing and the reproducibility of urinary mycotoxin assays. However, growing clinical reporting suggests that environmental mold exposure may represent an under-evaluated contributor to chronic inflammatory syndromes.
For medical professionals, the key takeaway may not be wholesale adoption of functional protocols, but careful consideration of environmental history in patients with unexplained multi-system illness.
Article source: Mold Toxicity Behind Inflammatory and Immune Disorders – MedicalExpo e-Magazine